Global Digital Pathology Market

Global Digital Pathology Market Size, Share, Growth Analysis, By Product(Software, device), By Application(Drug discovery & development, academic research) - Industry Forecast 2024-2031


Report ID: SQMIG35G2172 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 63 | Figures: 75

Global Digital Pathology Market Regional Insights

In 2022, North America dominated the global digital pathology market. This can be attributed to various factors, including increasing government initiatives towards the development of technologically advanced pathologies, continual investments in research and development, rising adoption of digital imaging, and the presence of key market players in the region. For instance, PathAI launched AISight, a digital pathology platform in 13 leading health systems across the U.S. to participate in an Early Access Program. The increasing usage of digital pathology in academic research and disease diagnosis is also contributing to the growth of the regional market.

Asia Pacific is expected to be the fastest-growing region in the digital pathology market, with a rising focus on investments in the medical field, rapid digitalization, and increasing digital imaging penetration in developing economies. The region is also witnessing a rising prevalence of cancer, which is driving the need for novel treatment options, thereby further propelling market growth. Qritive has recently entered into a collaboration with Corista for the integration of AI using the company's DP3, a DICOM-compliant pathology software in digital pathology. These initiatives help in providing better patient care, novel treatment options, and subsequently reducing laboratory cost expenses.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Digital Pathology Market size was valued at USD 0.97 billion in 2022 and is poised to grow from USD 1.05 billion in 2023 to USD 1.91 billion by 2031, at a CAGR of 7.8% during the forecast period (2024-2031).

The Global Digital Pathology Market is highly competitive, with a large number of players operating in the space. Some of the key players in the market are focused on product development and innovation, strategic partnerships and collaborations, and mergers and acquisitions to strengthen their market position. They are also investing heavily in research and development activities to develop advanced digital pathology solutions that offer improved accuracy, speed, and efficiency. In addition, companies are expanding their geographic reach by targeting emerging markets in Asia-Pacific and Latin America, which offer significant growth opportunities due to increasing healthcare expenditure and the rising prevalence of chronic diseases. Overall, the competitive landscape of the digital pathology market is expected to remain intense, with companies vying for a larger share of the rapidly growing market. 'Philips Healthcare (Netherlands)', 'Leica Biosystems (Germany)', 'Roche Diagnostics (Switzerland)', 'Hamamatsu Photonics (Japan)', '3DHISTECH (Hungary)', 'Ventana Medical Systems (US)', 'GE Healthcare (US)', 'Apollo Enterprise Imaging (US)', 'Olympus Corporation (Japan)', 'Mikroscan Technologies (US)', 'Inspirata (US)', 'PerkinElmer (US)', 'Huron Digital Pathology (Canada)', 'Sectra AB (Sweden)', 'PathAI (US)', 'Indica Labs (US)', 'F. Hoffmann-La Roche (Switzerland)', 'Nikon Corporation (Japan)', 'Danaher Corporation (US)', 'Visiopharm (Denmark)'

Continuous advancements in digital imaging technology, such as whole-slide imaging (WSI), high-resolution scanners, and image analysis software, are driving the adoption of digital pathology. These technological innovations offer improved image quality, faster scanning times, and enhanced analysis capabilities, leading to more accurate and efficient diagnoses. For example, the development of deep learning algorithms and artificial intelligence (AI) tools has enabled automated image analysis and detection of abnormalities in pathology slides, aiding pathologists in their decision-making process.

Telepathology and Remote Consultation: The increasing adoption of telepathology allows for remote diagnosis and consultation, enabling pathologists to collaborate and provide expert opinions regardless of geographical constraints. Telepathology has gained prominence during the COVID-19 pandemic, as it facilitates remote working and minimizes the risk of exposure for pathologists. For example, pathologists can remotely review and discuss cases with colleagues, participate in multidisciplinary tumor boards, or provide consultations to underserved areas or regions facing a shortage of pathology expertise.

In 2022, North America dominated the global digital pathology market. This can be attributed to various factors, including increasing government initiatives towards the development of technologically advanced pathologies, continual investments in research and development, rising adoption of digital imaging, and the presence of key market players in the region. For instance, PathAI launched AISight, a digital pathology platform in 13 leading health systems across the U.S. to participate in an Early Access Program. The increasing usage of digital pathology in academic research and disease diagnosis is also contributing to the growth of the regional market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Digital Pathology Market

Product ID: SQMIG35G2172

$5,300
BUY NOW GET FREE SAMPLE